Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

AR-12286

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Purpose:To evaluate the efficacy of rho-associated protein kinase inhibitor, AR-12286 topical solution, for its effect in eyes… Expand
Highly Cited
2014
Highly Cited
2014
Glaucoma is a progressive optic neuropathy that is a leading cause of irreversible blindness worldwide.1 Elevated intraocular… Expand
2013
2013
Background/aims To evaluate the ocular hypotensive efficacy, ocular and systemic safety, and systemic exposure of two… Expand
Highly Cited
2011
Highly Cited
2011
PURPOSE To evaluate the ocular hypotensive efficacy of 0.05%, 0.1% and 0.25% AR-12286 Ophthalmic Solutions in patients diagnosed… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
2010
2010
  • L. Hookes
  • IDrugs : the investigational drugs journal
  • 2010
  • Corpus ID: 26693573
The 2010 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO), held in Fort Lauderdale, FL, USA… Expand